News View all news
Update to asthma guidelines covers ICS, LAMAs, indoor allergy mitigation, more
In December 2020, the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee released a focused update to its 2007 asthma guidelines. The update covers select topics, such as intermittent use of inhaled corticosteroids (ICS), the role of long-acting muscarinic antagonists (LAMAs), indoor allergy mitigation, use of immunotherapy, bronchial thermoplasty, and fractional exhaled nitric oxide (FeNO) testing.
One and done: Why people are eager for Johnson & Johnson's vaccine
Many Americans have expressed a preference for Johnson & Johnson's coronavirus vaccine, even though its 72% efficacy rate lags that of the Pfizer and Moderna vaccines, which are about 95% effective. For recipients, the convenience of a single-dose is worth forfeiting the extra cushion of protection.
Biden promises enough coronavirus vaccine for 'every adult in America' by the end of May
President Biden announced Tuesday there will be ample COVID-19 vaccine for "every adult in America" to be protected by the end of May. That milestone previously was set for late July, but the pace has accelerated due to Johnson & Johnson's single-dose vaccine receiving emergency use authorization.
February 25, 2021
Goodbye to a hero, mentor, and friend
A true pharmacy icon, Dr. Joseph A. Oddis, left the Earth this week. He began his life of service to pharmacy and its patients as a young man, going on to become the CEO of ASHP for 37 years and the…0 comments
March 2, 2021
APhA, Physicians and Nurses Urge Bolstered Collection of Race and Ethnicity Data During COVID-19 Vaccinations
The American Pharmacists Association today joined two other leading national health care advocacy organizations to urge urged all health care professionals to redouble efforts to collect and report race and ethnicity data when administering COVID-19 vaccinations.
February 27, 2021
American Pharmacists Association Comment on Authorization of Janssen Vaccine: “We are Ready to Continue this Work”
Statement from Scott J. Knoer, MS, PharmD, FASHP, executive vice president and CEO of the American Pharmacists Association, upon the Food and Drug Administration’s (FDA) decision today to authorize emergency use of Janssen Biotech’s COVID-19 vaccine.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.